These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 25023249)

  • 1. Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.
    Lansdorp-Vogelaar I; Gulati R; Mariotto AB; Schechter CB; de Carvalho TM; Knudsen AB; van Ravesteyn NT; Heijnsdijk EA; Pabiniak C; van Ballegooijen M; Rutter CM; Kuntz KM; Feuer EJ; Etzioni R; de Koning HJ; Zauber AG; Mandelblatt JS
    Ann Intern Med; 2014 Jul; 161(2):104-12. PubMed ID: 25023249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
    Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
    Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.
    Trentham-Dietz A; Kerlikowske K; Stout NK; Miglioretti DL; Schechter CB; Ergun MA; van den Broek JJ; Alagoz O; Sprague BL; van Ravesteyn NT; Near AM; Gangnon RE; Hampton JM; Chandler Y; de Koning HJ; Mandelblatt JS; Tosteson AN;
    Ann Intern Med; 2016 Nov; 165(10):700-712. PubMed ID: 27548583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
    Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
    Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
    JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits and Harms of Mammography Screening in 75 + Women to Inform Shared Decision-making: a Simulation Modeling Study.
    Jayasekera J; Stein S; Wilson OWA; Wojcik KM; Kamil D; Røssell EL; Abraham LA; O'Meara ES; Schoenborn NL; Schechter CB; Mandelblatt JS; Schonberg MA; Stout NK
    J Gen Intern Med; 2024 Feb; 39(3):428-439. PubMed ID: 38010458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient preferences for breast cancer screening: a systematic review update to inform recommendations by the Canadian Task Force on Preventive Health Care.
    Pillay J; Guitard S; Rahman S; Saba S; Rahman A; Bialy L; Gehring N; Tan M; Melton A; Hartling L
    Syst Rev; 2024 May; 13(1):140. PubMed ID: 38807191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms.
    Mandelblatt JS; Cronin KA; Bailey S; Berry DA; de Koning HJ; Draisma G; Huang H; Lee SJ; Munsell M; Plevritis SK; Ravdin P; Schechter CB; Sigal B; Stoto MA; Stout NK; van Ravesteyn NT; Venier J; Zelen M; Feuer EJ;
    Ann Intern Med; 2009 Nov; 151(10):738-47. PubMed ID: 19920274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness of alternative prostate-specific antigen--based prostate cancer screening strategies: model estimates of potential benefits and harms.
    Gulati R; Gore JL; Etzioni R
    Ann Intern Med; 2013 Feb; 158(3):145-53. PubMed ID: 23381039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk.
    van Ravesteyn NT; Miglioretti DL; Stout NK; Lee SJ; Schechter CB; Buist DS; Huang H; Heijnsdijk EA; Trentham-Dietz A; Alagoz O; Near AM; Kerlikowske K; Nelson HD; Mandelblatt JS; de Koning HJ
    Ann Intern Med; 2012 May; 156(9):609-17. PubMed ID: 22547470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of false-positive results for future cancer screenings.
    Taksler GB; Keating NL; Rothberg MB
    Cancer; 2018 Jun; 124(11):2390-2398. PubMed ID: 29682740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force.
    Knudsen AB; Rutter CM; Peterse EFP; Lietz AP; Seguin CL; Meester RGS; Perdue LA; Lin JS; Siegel RL; Doria-Rose VP; Feuer EJ; Zauber AG; Kuntz KM; Lansdorp-Vogelaar I
    JAMA; 2021 May; 325(19):1998-2011. PubMed ID: 34003219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
    Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
    JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.
    Sprague BL; Stout NK; Schechter C; van Ravesteyn NT; Cevik M; Alagoz O; Lee CI; van den Broek JJ; Miglioretti DL; Mandelblatt JS; de Koning HJ; Kerlikowske K; Lehman CD; Tosteson AN
    Ann Intern Med; 2015 Feb; 162(3):157-66. PubMed ID: 25486550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study.
    Miglioretti DL; Lange J; van den Broek JJ; Lee CI; van Ravesteyn NT; Ritley D; Kerlikowske K; Fenton JJ; Melnikow J; de Koning HJ; Hubbard RA
    Ann Intern Med; 2016 Feb; 164(4):205-14. PubMed ID: 26756460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force.
    Knudsen AB; Zauber AG; Rutter CM; Naber SK; Doria-Rose VP; Pabiniak C; Johanson C; Fischer SE; Lansdorp-Vogelaar I; Kuntz KM
    JAMA; 2016 Jun; 315(23):2595-609. PubMed ID: 27305518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engaging Patients in Decisions About Cancer Screening: Exploring the Decision Journey Through the Use of a Patient Portal.
    Woolf SH; Krist AH; Lafata JE; Jones RM; Lehman RR; Hochheimer CJ; Sabo RT; Frosch DL; Zikmund-Fisher BJ; Longo DR
    Am J Prev Med; 2018 Feb; 54(2):237-247. PubMed ID: 29241715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicians' perceptions of the benefits and harms of prostate and colorectal cancer screening.
    Elstad EA; Sutkowi-Hemstreet A; Sheridan SL; Vu M; Harris R; Reyna VF; Rini C; Earp JA; Brewer NT
    Med Decis Making; 2015 May; 35(4):467-76. PubMed ID: 25637592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening Mammography Among Older Women: A Review of United States Guidelines and Potential Harms.
    Mack DS; Lapane KL
    J Womens Health (Larchmt); 2019 Jun; 28(6):820-826. PubMed ID: 30625008
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.